Correlation Between Tarsus Pharmaceuticals and Mountain Crest

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Mountain Crest at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Mountain Crest into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Mountain Crest Acquisition, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Mountain Crest and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Mountain Crest. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Mountain Crest.

Diversification Opportunities for Tarsus Pharmaceuticals and Mountain Crest

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Tarsus and Mountain is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Mountain Crest Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mountain Crest Acqui and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Mountain Crest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mountain Crest Acqui has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Mountain Crest go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Mountain Crest

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.57 times more return on investment than Mountain Crest. However, Tarsus Pharmaceuticals is 1.74 times less risky than Mountain Crest. It trades about 0.15 of its potential returns per unit of risk. Mountain Crest Acquisition is currently generating about -0.28 per unit of risk. If you would invest  2,884  in Tarsus Pharmaceuticals on September 15, 2024 and sell it today you would earn a total of  2,366  from holding Tarsus Pharmaceuticals or generate 82.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy15.08%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Mountain Crest Acquisition

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Mountain Crest Acqui 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mountain Crest Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Mountain Crest is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Tarsus Pharmaceuticals and Mountain Crest Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Mountain Crest

The main advantage of trading using opposite Tarsus Pharmaceuticals and Mountain Crest positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Mountain Crest can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mountain Crest will offset losses from the drop in Mountain Crest's long position.
The idea behind Tarsus Pharmaceuticals and Mountain Crest Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum